Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 9, 2009 - Issue 5
Submit an article Journal homepage
203
Views
16
CrossRef citations to date
0
Altmetric
Drug Evaluations

The use of agalsidase alfa enzyme replacement therapy in the treatment of Fabry disease

Chantal F Morel University Health Network and Mount Sinai Hospital, University of Toronto, Department of Medicine, 60 Murray Street, Box 34, 3rd Floor, Room 400, Toronto, Ontario, M5T 3L9, Canada +1 416 586 4800 ext. 4220; +1 416 619 5523; [email protected]
&
Joe TR Clarke The Hospital for Sick Children, Division of Clinical and Metabolic Genetics, Toronto, Ontario, Canada, USA; Centre Hospitalier Universitaire de Sherbrooke, Service de Génétique Médicale, Sherbrooke, Québec, Canada, USA
Pages 631-639 | Published online: 16 Apr 2009

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Wei Ge, Bin Wei, Hao Zhu, Zhigang Miao, Weimin Zhang, Cuihua Leng, Jizhen Li, Dan Zhang, Miao Sun & Xingshun Xu. (2017) A novel mutation of α-galactosidase A gene causes Fabry disease mimicking primary erythromelalgia in a Chinese family. International Journal of Neuroscience 127:5, pages 448-453.
Read now
Priti Katrolia, Eranna Rajashekhara, Qiaojuan Yan & Zhengqiang Jiang. (2014) Biotechnological potential of microbial α-galactosidases. Critical Reviews in Biotechnology 34:4, pages 307-317.
Read now
Majid Alfadhel & Sandra Sirrs. (2011) Enzyme replacement therapy for Fabry disease: some answers but more questions. Therapeutics and Clinical Risk Management 7, pages 69-82.
Read now

Articles from other publishers (13)

Yiwei Fan, Xiaoling Lu, Junlong Zhao, Haoda Fu & Yufeng Liu. (2022) Estimating individualized treatment rules for treatments with hierarchical structure. Electronic Journal of Statistics 16:1.
Crossref
C.H. Vidya, B.S. Gnanesh Kumar, C.V. Chinmayee & Sridevi Annapurna Singh. (2020) Purification, characterization and specificity of a new GH family 35 galactosidase from Aspergillus awamori. International Journal of Biological Macromolecules 156, pages 885-895.
Crossref
Carola Schröder, Viktoria-Astrid Janzer, Georg Schirrmacher, Jörg Claren & Garabed Antranikian. (2016) Characterization of two novel heat-active α-galactosidases from thermophilic bacteria. Extremophiles 21:1, pages 85-94.
Crossref
Samuel J. Aronson & Heidi L. Rehm. (2015) Building the foundation for genomics in precision medicine. Nature 526:7573, pages 336-342.
Crossref
Sergey Yur'yevich Astakhov, Natal'ya Viktorovna Tkachenko & Sanasar Surikovich Papanyan. (2015) Cordarone keratopathyand Fabry disease: Differential diagnosis, treatment. Ophthalmology Reports 8:2, pages 71-78.
Crossref
Martin L. Katz, Joan R. Coates, Christine M. Sibigtroth, Jacob D. Taylor, Melissa Carpentier, Whitney M. Young, Fred A. Wininger, Derek Kennedy, Brian R. Vuillemenot & Charles A. O'Neill. (2014) Enzyme replacement therapy attenuates disease progression in a canine model of late‐infantile neuronal ceroid lipofuscinosis ( CLN 2 disease) . Journal of Neuroscience Research 92:11, pages 1591-1598.
Crossref
Martin DalzielMax CrispinChristopher N. ScanlanNicole ZitzmannRaymond A. Dwek. (2014) Emerging Principles for the Therapeutic Exploitation of Glycosylation. Science 343:6166.
Crossref
Heidi L. Rehm. (2013) Disease-targeted sequencing: a cornerstone in the clinic. Nature Reviews Genetics 14:4, pages 295-300.
Crossref
Rose-Mary Boustany, Ibraheem Al-Shareef & Sariah El-Haddad. 2013. Emery and Rimoin's Principles and Practice of Medical Genetics. Emery and Rimoin's Principles and Practice of Medical Genetics 1 85 .
A. Zampetti, C.H. Orteu, D. Antuzzi, M.R. Bongiorno, S. Manco, M. Gnarra, A. Morrone, G. Cardinali, D. Kovacs, N. Aspite, D. Linder, R. Parini & C. Feliciani. (2012) Angiokeratoma: decision-making aid for the diagnosis of Fabry disease. British Journal of Dermatology 166:4, pages 712-720.
Crossref
Kristin M. Hammersmith, Renata A. Rezende, Elisabeth J. Cohen, Ralph C. EagleJrJr & Christopher J. Rapuano. 2011. Cornea. Cornea 239 265 .
. 2010. Cerebellar Disorders. Cerebellar Disorders 88 101 .
Joe T.R. Clarke. 2010. Fabry Disease. Fabry Disease 489 497 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.